Cytomegalovirus retinitis in the era of highly active antiretroviral therapy

International Ophthalmology Clinics

Volumn 40, Issue 2, 2000, Pages 127-135

  Zegans, Michael ^a   Marsh, Bryan ^a   Walton, R Christopher ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC THERAPY; CYTOMEGALOVIRUS; HUMAN; IMMUNITY; LYMPHOCYTE COUNT; MAINTENANCE THERAPY; PRIORITY JOURNAL; RETINITIS; REVIEW; VIRUS LOAD;

EID: 0034062013     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-200004000-00010     Document Type: Review

References (34)

1. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853-860
2. Concorde Coordinating Committee. Concorde: 〈RC/ANRS randomized double-blind controlled trial of immediate and deferred zidovudine in symptom free HIV infection. Lancet 1994;343:871-881
3. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patient infected with HIV-1 Lancet 1998;352:1725-1730
4. Connick E, Lederman M, Kotzin B, et al. Immunologic effects of 48 weeks of AZT/3TC/ritonavir. In: Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections, Alexandria, VA: Westover Management Group, 1998
5. Ledergerber B, Egger M, Opravil M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Lancet 1999;353:863-868
6. Smith ME. Retinal involvement in adult cytomegalic inclusion disease. Arch Ophthalmol 1964;72:44-49
7. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis: multicenter AIDS cohort study. N Engl J Med 1993;329: 1922-1926
8. Kupperman BD, Petty JG, Richmand DD, et al. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993;115:575-582
9. Elkins BS, Holland GN, Opremcak EM, et al. Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology 1994; 101:499-507
10. Jabs DA, Bartlett JG. AIDS and ophthalmology: a period of transition. Am J Ophthalmol 1997;124:227-233
11. Jacobson MA, French M. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy. AIDS 1998;12(supplA): S157-S163
12. D'Amico DJ, Skolnik PR, Kosloff BR, et al: Resolution of cytomegalovirus retinitis with zidovudine therapy. Arch Ophthalmol 1988;106:1168-1169
13. Reed JB, Schwab IR, Gordon J, Morse LS. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am J Ophthalmol 1997; 124:199-205
14. Whitcup SM, Cunningham ET Jr, Polis MA, Fortin E. Spontaneous and sustained resolution of CMV retinitis in patients receiving highly active antiretroviral therapy (letter). Br J Ophthalmol 1998;82(7):845-847
15. Uthayakumar S, Birthistle K, Hay PE. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy (correspondence). Lancet 1997;350(9077):588-589
16. Tural C, Romeu J, Sirera G, et al. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis 1998;177(4):1080-1083
17. Jabs DA, Bolton SG, Dunn JP, Palestine AG. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. Am J Ophthalmol 1998;126(6):817-822
18. + patients. Br J Ophthal 1998;82(9):998-990
19. Jacobson M, Zegans M, Pavan P, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-1445
20. Michelet C, Arvieux C, Aubert V, et al. Viral ocular involvement after initiation of protease inhibitor therapy. Presented at the Fourth Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997
21. Karavellas MP, Lowder CY, Macdonald C, et al. Immune recovery vitritis associated with inactive cytomegalovirus retinitis. Arch Ophthalmol 1997;116:169-175
22. Zegans ME, Walton RC, Holland GN, et al. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1998;125:292-300
23. Karavellas MP, Plummer DJ, Macdonald JC, et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis 1999;179(3):697-700
24. Cassaoux N, Lumbroso L, Bodaghi B, et al. Cystoid macular oedema and cytomegalovirus retinitis in patient with HIV disease treated with highly active antiretroviral therapy. Br J Ophthalmol 1999;83(1):47-49
25. Canzano JC, Reed JB, Morse LS. Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patient with cytomegalovirus retinitis. Retina 1998; 18:443-447
26. Sanislo SR, Lowder CY, Kaiser PK. Optic nerve head neovascularization in a patient with inactive cytomegalovirus retinitis and immune recovery. Am J Ophthalmol 1998;126: 318-320
27. Herbort CP, Chave JP. Cicatrization of cytomegalovirus retinitis following introduction of highly active antiretroviral therapy: uveitis as a possible good prognosis. Graefes Arch Clin Exp Ophthalmol 1998;236(10):795-797
28. Komaduri KV, Viswannathan MN, Wieder ED, et al. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individual with HIV-1. Nature Med 1998;4(8):953-956
29. Race E, Adelson-Mitty J, Barlam T, Japour A. Focal inflammatory lymphadenitis (FIL) and fever following initiation of protease inhibitor (PRI) in patients with advanced HIV-1 disease. Presented at the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997
30. Mills RW. Ocular cytomegalic inclusion disease in the adult. Trans Ophthalmol Soc UK 1977;97:500-504
31. 1999 USPHS/IDSA guideline for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1999;48(RR10):1-59
32. Martin DF, Dunn JP, Davis JL, et al. Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society - USA Panel. Am J Ophthalmol 1999;127:329-339
33. Condra JH, Schleif WA, Blahy OM, et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 1995;374:569-571
34. Boden D, Hurley A, Zhang L, et al. HIV-1 drug resistance in newly infected individuals. JAMA 1999;282(12):1135-1141